Drug recall · July 18, 2018
Admelog Solostar recall
Why: Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00
- Lots / codes
Lot #: 7F021B, Exp 6/30/20
- Quantity
- 3214 prefilled pens
- Company
- Sanofi-Aventis U.S. LLC, Bridgewater, NJ
- Distribution
- Nationwide
- Initiated
- July 5, 2018 · Voluntary: Firm initiated
- Classified
- July 16, 2018
- Reported
- July 18, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Admelog
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.